HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Taiji Sakamoto Selected Research

Polypoidal Choroidal Vasculopathy

4/2024Evaluating photodynamic therapy versus brolucizumab as a second-line treatment for polypoidal choroidal vasculopathy.
10/2023Anti-VEGF Treatment Strategies for 3 Subtypes of Neovascular Age-Related Macular Degeneration in a Clinical Setting: A Multicenter Cohort Study in Japan.
1/2022Visual prognosis of submacular hemorrhage secondary to age-related macular degeneration: A retrospective multicenter survey.
1/2017Changes of choroidal structure after intravitreal aflibercept therapy for polypoidal choroidal vasculopathy.
1/2017One-Year Outcomes following Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in Japanese Patients: The APOLLO Study.
10/2013Choroidal venous pulsations at an arterio-venous crossing in polypoidal choroidal vasculopathy.
8/2013Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab.
8/2005Visual improvement following trans-Tenon's retrobulbar triamcinolone acetonide infusion for polypoidal choroidal vasculopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Taiji Sakamoto Research Topics

Disease

33Retinal Detachment (Retinal Detachments)
12/2023 - 03/2002
26Retinal Perforations
04/2024 - 09/2004
26Macular Edema
01/2024 - 06/2002
23Diabetic Retinopathy (Retinopathy, Diabetic)
01/2021 - 03/2002
19Macular Degeneration (Age-Related Maculopathy)
10/2023 - 09/2003
13Inflammation (Inflammations)
10/2018 - 09/2003
11Endophthalmitis (Ophthalmia)
10/2023 - 11/2003
10Epiretinal Membrane (Epiretinal Membranes)
01/2024 - 12/2007
9Retinal Vein Occlusion
01/2024 - 04/2006
9Cataract (Cataracts)
01/2023 - 10/2004
9Glaucoma
12/2021 - 07/2002
8Polypoidal Choroidal Vasculopathy
04/2024 - 08/2005
8Choroidal Neovascularization
01/2020 - 09/2003
7Central Serous Chorioretinopathy
12/2023 - 01/2016
6Retinal Diseases
09/2023 - 06/2002
5Vision Disorders (Hemeralopia)
01/2024 - 03/2019
5Blindness (Hysterical Blindness)
09/2023 - 01/2013
5Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
01/2019 - 01/2016
5Uveitis
06/2011 - 09/2003
4Wounds and Injuries (Trauma)
04/2024 - 05/2014
4Neoplasms (Cancer)
01/2023 - 03/2007
4Vitreous Hemorrhage
01/2022 - 06/2010
4Proliferative Vitreoretinopathy
06/2016 - 06/2002
4Hemorrhage
01/2013 - 03/2007
3Neovascular Glaucoma
10/2019 - 05/2005
3Melanoma (Melanoma, Malignant)
07/2008 - 03/2007
2Hypertension (High Blood Pressure)
06/2020 - 10/2019
2Intraocular Lymphoma
10/2015 - 07/2011
2Vitreous Detachment (Posterior Vitreous Detachment)
06/2014 - 03/2008
2Necrosis
03/2011 - 03/2007
2Sexually Transmitted Diseases (Sexually Transmitted Disease)
07/2009 - 04/2008
1Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
04/2024
1COVID-19
10/2023
1Pressure Ulcer (Bedsore)
09/2023
1Eye Pain
09/2023
1Atopic Dermatitis (Atopic Eczema)
02/2023
1Acquired Immunodeficiency Syndrome (AIDS)
01/2023
1Angle-Closure Glaucoma (Glaucoma, Angle Closure)
07/2022
1Optic Neuritis (Retrobulbar Neuritis)
07/2021
1Microaneurysm
01/2021
1Refractive Errors (Refractive Error)
01/2020
1Cerebral Infarction
03/2019
1Neuromyelitis Optica (Devic's Disease)
09/2018

Drug/Important Bio-Agent (IBA)

35Retinaldehyde (Retinal)IBA
04/2024 - 02/2002
29Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2024 - 09/2003
27Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
03/2019 - 02/2003
10Ranibizumab (Lucentis)FDA Link
10/2023 - 08/2013
10Triamcinolone (Aristocort)FDA Link
03/2013 - 06/2002
8afliberceptIBA
01/2024 - 01/2017
8Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2018 - 10/2004
7Bevacizumab (Avastin)FDA Link
01/2017 - 05/2008
7CytokinesIBA
04/2014 - 12/2003
61-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2024 - 06/2014
6Adrenal Cortex Hormones (Corticosteroids)IBA
12/2016 - 04/2006
5SteroidsIBA
07/2021 - 03/2010
5Proteins (Proteins, Gene)FDA Link
01/2014 - 03/2007
4Phenobarbital (Luminal)FDA Link
01/2020 - 03/2015
4InterleukinsIBA
03/2011 - 11/2005
3Silicone OilsIBA
01/2022 - 09/2008
3Interleukin-6 (Interleukin 6)IBA
04/2014 - 12/2009
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2013 - 12/2007
2faricimabIBA
01/2024 - 09/2023
2Biosimilar PharmaceuticalsIBA
10/2023 - 08/2023
2Sulfur HexafluorideIBA
01/2022 - 02/2003
2AntibodiesIBA
07/2021 - 09/2011
2Interleukin-10 (Interleukin 10)IBA
03/2017 - 03/2011
2Histones (Histone)IBA
11/2014 - 05/2014
2LipidsIBA
01/2013 - 03/2007
2Interleukin-8 (Interleukin 8)IBA
03/2011 - 11/2003
2Chemokine CCL5IBA
12/2009 - 09/2003
2HMGB1 Protein (HMG1)IBA
03/2009 - 07/2008
2Ophthalmic Solutions (Eye Drops)IBA
03/2005 - 01/2004
2SolutionsIBA
10/2004 - 06/2002
1brolucizumabIBA
04/2024
1Angiopoietin-2IBA
01/2024
1CoagulaseIBA
01/2023
1FluorocarbonsIBA
01/2023
1Myelin-Oligodendrocyte GlycoproteinIBA
07/2021
1CoagulantsIBA
06/2020
1AnticoagulantsIBA
10/2019
1Coloring Agents (Dyes)IBA
01/2019
1Immunoglobulin G (IgG)IBA
09/2018

Therapy/Procedure

58Vitrectomy
10/2023 - 03/2002
20Therapeutics
04/2024 - 09/2007
10Scleral Buckling
02/2023 - 01/2008
9Intravitreal Injections
10/2018 - 06/2002
8Lasers (Laser)
07/2022 - 09/2011
7Photochemotherapy (Photodynamic Therapy)
04/2024 - 06/2014
7Aftercare (After-Treatment)
09/2023 - 04/2006
6Traction
01/2024 - 11/2005
6Light Coagulation
06/2020 - 07/2002
5Operative Surgical Procedures
06/2020 - 02/2006
4Injections
01/2021 - 09/2011
3Filtering Surgery
12/2007 - 12/2003
2Intraocular Lens Implantation
01/2013 - 04/2006
2Ligation
01/2013 - 05/2002
1Surgical Instruments (Clip)
01/2024
1Preoperative Period
01/2022
1Trabeculectomy (Trabeculoplasty)
12/2021
1Contraindications
03/2019